AstraZeneca
cash flow net debt and financial guidance continued improvement net debt bridge reiterating guidance total revenue excluding covid medicines low double digit growth including covid medicines low to mid single digit growth core high single digit to low double digit net debt a low single digit adverse impact anticipated for both total revenue and core in | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
April 2023
Slide
11 of 41
Similar slides by AstraZeneca
See diffirences between slides (animation)
Results
February 2024
net debt and capital allocation delivered continued cash flow improvement net debt bridge capital allocation net debt adjusted priority remains in the business | AstraZeneca
Results
November 2023
cash flow net debt and financial guidance continued improvement net debt bridge updated guidance total revenue mid single digit increase previously low to mid single digit increase total revenue excluding covid medicines low teens increase previously low double digit increase core low double digit to low teens increase previously high single digit to low double digit increase | AstraZeneca
Results
July 2023
cash flow net debt and financial guidance continued improvement net debt bridge reiterating guidance total revenue core | AstraZeneca
Results
February 2023
net debt and cash flow strong cash flow from operations delivered improved cash flow in net debt bridge strong investment grade credit rating reinvestment in the business value enhancing business development progressive dividend policy net debt | AstraZeneca
Related slides by other companies
Centerview Partners
Investment Banking
July 2017
pro emergence balance sheet scenarios summary total debt plus pension adjusted total debt less cash adjusted net debt memo net debt sig | Centerview Partners
DiamondRock Hospitality
Investor Presentation
November 2023
at a glance portfolio financial summary diversified geography rooms properties geographic markets diversified properties revenue total debt | DiamondRock Hospitality
Canada Goose
Investor Presentation
November 2022
quarterly outlook outlook | Canada Goose
jetBlue
Results
May 2020
taking actions to protect our stakeholders balance sheet earnings of liquidity at close added net in for a total of or of revenue estimate cash burn of below day in may down from day average in the second half of march adjusted debt to equal to adjusted debt to cap ratio at revenue down yoy a decline mitigated by close in capacity cuts in march and a reduction in plan covid impact resulted in a loss per share of cents and non loss per share of cents planning assumptions other liquidity actions expect yoy revenue down at least cares act payroll support program payment received for capacity cuts of at least yoy and a reduction of may of yoy evaluating additional capital raises including secured debt and for now lower by plan sale current assumption as does not constitute guidance excluding | jetBlue
Other recent decks by AstraZeneca
See all presentations (27 decks)
Results
February 2024
Investor Conference
January 2024
Results
November 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io